Efficacy of Early Short-term Training on Thrombogenesis in Patients Following Coronary Bypass Surgery

November 3, 2016 updated by: Chang Gung Memorial Hospital

Although the benefit of cardiac rehabilitation following coronary artery bypass graft (CABG) is well-established, it is underused. The current investigation will adopt an early, intensive, short-term and supervised aerobic training at moderate-intensity. The inclusion criteria are diagnosed coronary artery disease (CAD) and clinical indication for elective first-time CABG.

Regular physical exercise is associated with overall reduced risk of primary cardiac arrest. Previous study demonstrated that moderate-intensity exercise training reduced resting and strenuous exercise-induced activation of platelet and possibly coagulation. Our main research question is that whether the short-term CR program in the present investigation will ameliorate hemostatic imbalance at rest and platelet coagulation activation at maximal stress exercise.

This is designed to be a prospective randomized controlled study. Sixty men who are scheduled to receive elective CABG in Chang Gung Memorial Hospital at Linkuo will be enrolled in the study. They will be randomized into two groups: intensive training (IT) and usual rehabilitation (UR). Participants in the IT group will receive intensive aerobic training at moderate intensity after CABG. A submaximal exercise test will be performed for intensity prescription. They will receive two training sessions per day and at least 20 sessions in total. The CR group will receive usual CR program. After intervention, each participant will receive a maximal exercise test. Additionally, six-minute walk test, generic and disease-specific quality of life, will be collected before and after training. Additional 20 age-matched non-sedentary and healthy men without training will be recruited as control group.

Venous blood will be sampled three times (before and after rehabilitation and maximal stress test) for the assessment of platelet activation by flow cytometer and activity of coagulation factors. Mean platelet volume, and platelet activation markers (platelet-bound CD62P%G, CD63%G, CD40L%G) will be analyzed. Various coagulation and fibrinolysis factors will be quantified.

We hypothesized that this training program will ameliorate the prothrombotic state and attenuate platelet reactivity and coagulation induced by strenuous exercise in patients after CABG. Hopefully, this clinical investigation will establish an early short-term rehabilitation model following CABG and its efficacy for clinical use.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Introduction

The American College of Cardiology/American Heart Association guidelines suggested that cardiac rehabilitation (CR) should be offered to all eligible patients after coronary bypass surgery (CABG).[1] However, CR use in America is relatively low among Medicare beneficiaries despite convincing evidence of its benefits and recommendations for its use by professional organizations.[2] This neglect is as well evident in Taiwan. Traffic inconvenience and unavailability due to working hours are the common causes. There are ways to mend this situation. One of them is to develop an early, intensive and short-term CR program. The current investigation will adopt an early, intensive and supervised training for male patients following elective CABG due to old myocardial infarction and/or angina pectoris.

Meta-analyses of randomized controlled trials have consistently shown that participation in CR programs improves mortality and morbidity outcomes. It also benefits cardiopulmonary fitness, quality of life, lipid profile, etc.[3] Nonetheless, research regarding its effect on balance of thrombogenesis at rest or in response to vigorous exercise is either incomplete or controversial.

Previous studies found that acute physical exertion may trigger an acute coronary syndrome. The relative risk of cardiac events was 2-6 times higher during strenuous physical exertion (>6 METs) compared with during mild to moderate intensity activities in cardiac patients.[4] One of the possible explanations for this is that acute physical exertion may acutely change the hemostatic milieu in favor of increased coagulation and activation of platelet.[5] Available evidence suggests that strenuous exercise, in both healthy subjects and in various cardiovascular disease states, is associated with activation of platelets and blood coagulation, leading to a prothrombotic or hypercoagulable state.[6, 7] Aspirin is ineffective in attenuating enhanced platelet aggregation and activation induced by exercise.[8]

Regular physical exercise is associated with overall reduced risk of primary cardiac arrest.[4] D Wosornu et al. showed that a three-month aerobic training program (3 sessions per week) decreased resting fibrinogen concentration.[9] A meta-analysis showed that an exercise intervention over 2 weeks is associated with reduced inflammatory activity in patients with coronary artery disease (CAD). C-reactive protein and fibrinogen have provided the strongest evidence.[10] Platelet activation by strenuous exercise has been studied in 12 physically active and 12 sedentary individuals before and after a standardized treadmill exercise test. Among sedentary subjects, exercise caused an augmentation of the platelet activation and reactivity. In contrast, in physically active subjects exercise failed to induce alteration in platelet activation state.[11] Our previous study identified that moderate-intensity exercise training (60% maximal oxygen consumption for 30 min per day, 5 days/week for 8 weeks) reduced resting and strenuous exercise-induced platelet aggregation and platelet adhesion under shear flow in healthy men,[12] which were accompanied by decreased vWF binding to platelets and expression of P-selectin on platelets.[13] Accordingly, our main research question is that whether the short-term CR program in the current investigation ameliorates hemostatic imbalance at rest and platelet and coagulation activation at maximal stress exercise.

This is a prospective randomized controlled study. Sixty men who are scheduled to receive elective CABG in Chang Gung Memorial Hospital at Linkuo will be enrolled in the study. They will be randomized into two groups: intensive training (IT) and usual rehabilitation (UR). Participants in the IT group will receive education, reconditioning exercise and early intensive aerobic training at moderate intensity after CABG. A submaximal exercise test will be performed for prescription. They will receive two training sessions per day and at least 22 sessions in total. The CR group will receive usual CR program. After intervention, the participant will receive a maximal exercise test. In addition, six-minute walk test, generic and disease-specific quality of life will be collected before and after rehabilitation. Additional 20 age-matched, non-sedentary healthy participants without training will be recruited as control group.

Venous blood will be sampled three times (before and after rehabilitation and maximal stress test) for the assessment of platelet activation by flow cytometer and hemorheological profile by coagulation analyzer. Mean platelet volume, and platelet activation markers (platelet-bound CD62P%G, CD63%G, CD40L%G) will be analyzed. Various coagulation and fibrinolysis factors will be quantified including PT, aPTT, fibrinogen, thrombin time, FVIII:C, antithrombin, plasminogen, antiplasmin, anti-Xa and thrombin generation, D-Dimer, vWF etc.

We hypothesized that this training program will ameliorate the prothrombotic state and attenuate platelet reactivity and coagulation induced by strenuous exercise in patients after CABG. Hopefully, this clinical investigation will establish an early short-term rehabilitation model following CABG and its efficacy for clinical use.

Methodology

Participants A prospective study will be performed within the Cardiovascular Ward of Chang Gung Memorial Hospital, Linkuo. The inclusion criteria is diagnosed CAD and scheduled to receive elective CABG. Patients awaiting first-time elective CABG will be invited to participate in the study, and enrolled after giving written informed consent. Sixty patients will be enrolled. Exclusion criteria are musculoskeletal or neurological impairment precluding performance of cycling and walking assessment, atrial fibrillation, receiving anticoagulation therapy, inability to complete questionnaires, planned concomitant surgery, and a clinical status which requires emergent CABG. Additional 20 non-sedentary, age-matched healthy subjects without cardiovascular illness will be recruited as the control group. Non-sedentary life style is defined as walking more than 25 minutes in average per day according to the National Population Health Surveys of Canada. [14]

Randomization The patients will be randomized to two treatment groups (see Table 1 below) following assessment of study eligibility but prior to initial physiotherapy assessment. Randomization will be performed by means of random number generator based on their medical chart number. Thirty patients will be allocated to receive usual rehabilitation (UR); 30 to intensive training (IT).

Intervention protocol Physiotherapy interventions received by the two study groups are documented in Table 1. The IT group will receive physiotherapy twice daily with longer duration and higher intensity. After postoperative day5th, the training intensity will be prescribed at ventilatory anaerobic threshold (VAT) based on the submaximal exercise test in which the end point is supra-VAT. All physiotherapy interventions will be undertaken by one physiotherapist, specifically trained in the education and treatment methods used in the study.[15-17]

Supplemental oxygen will be used for all supervised/assisted walks if resting oxygen saturations is <92%. If patients are in sinus tachycardia (defined as >120 beats/min at rest) without hemodynamic compromise, exercise will be undertaken at a "comfortable" pace rather than at a "moderate" or "somewhat strong" level of perceived exertion. Patients will be counseled not to do walking training outside of physiotherapy sessions.

All patients will receive outcome assessment including cardiopulmonary exercise test, 6-minute-walk, quality of life, and hemorheological profile at basal and after strenuous exercise (Figure 1).

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
    • Taoyuan
      • Linkuo, Taoyuan, Taiwan, 333
        • Chang Gung Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • CAD and scheduled to receive elective CABG. Male patients awaiting first-time elective CABG will be invited to participate in the study, and enrolled after giving written informed consent.

Exclusion Criteria:

  • musculoskeletal or neurological impairment precluding performance of cycling and walking assessment
  • receiving anticoagulation therapy
  • inability to complete questionnaires
  • a clinical status which requires emergent CABG
  • end-stage renal disease
  • peripheral arterial occlusive disease
  • untreated life-threatening cardiac arrythmias
  • acute heart failure
  • uncontrolled hypertension
  • advanced atrioventricular block
  • acute myocarditis or pericarditis
  • acute systemic illness
  • intracardiac thrombus
  • progressive worsening of exercise tolerance or dyspnea at rest over previous 3-5 days
  • significant ischemia during low-intensity exercise (< 2 metabolic equivalent of tasks,< 50W)
  • uncontrolled diabetes
  • atrial fibrillation
  • atrial flutter
  • concurrent continuous or intermittent dobutamine therapy
  • decrease in systolic blood pressure with exercise
  • New York Heart Association (NYHA) class IV
  • supine resting heart rate > 100 bpm

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intensive training
intensive aerobic training in moderate intensity day5 postoperatively. 30 minutes per sessions, 2 sessions per day, 10 sessions per week. There will be 20 sessions in total.
Behavioral: Intensive training
The IT group will receive physiotherapy twice daily with longer duration and higher intensity
Sham Comparator: traditional training
traditional rehabilitation
Behavioral: traditional training
usual care: conventional rehabilitation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiopulmonary fitness
Time Frame: 3 days to 4 weeks after coronary bypass
before and after rehabilitation platelet activation before and after stress test
3 days to 4 weeks after coronary bypass

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
platelet activity(composite measure)
Time Frame: 3 days to 4 weeks after coronary bypass
by flow cytometry
3 days to 4 weeks after coronary bypass

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
cardiovascular event
Time Frame: 3 weeks ~ 4 weeks s/p CABG
acute myocardial infarction, hemodynamic instability during exercise training(SBP drop, ventricular tachycardia,...)
3 weeks ~ 4 weeks s/p CABG

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Chang Gung Memorial Hospital

Investigators

  • Principal Investigator: Shu-Chun Huang, Chang Gung Memorial Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2013

Primary Completion (Actual)

July 1, 2016

Study Completion (Actual)

July 1, 2016

Study Registration Dates

First Submitted

May 1, 2014

First Submitted That Met QC Criteria

May 21, 2014

First Posted (Estimate)

May 22, 2014

Study Record Updates

Last Update Posted (Estimate)

November 4, 2016

Last Update Submitted That Met QC Criteria

November 3, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 102-3049A3

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Clinical Trials on Intensive training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe